Navigation Links
Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)

annual relapse rate prior to entry, versus patients who received the 20 mg dose (62 percent reduction). The time to the first relapse was significantly delayed from 80 days in the 20 mg group to 213 days in the 40 mg group (p = 0.0367). The overall safety profile was similar to that of the 20 mg dose. Some features of injection site reactions and immediate post-injection reactions were more common.

About Multiple Sclerosis

Multiple Sclerosis (MS) is the leading cause of neurological disability in young adults. It is estimated that 400,000 people in the United States are affected by this disease, and that over two million people are affected worldwide. MS is a progressive, demyelinating disease of the central nervous system affecting the brain, spinal cord and optic nerves.

Patients with MS may experience physical symptoms and/or cognitive impairments, including weakness, fatigue, ataxia, physical dysfunction, bladder and bowel problems, sensory effects, and visual impairment. MS also has a significant impact on the sufferers' social functioning and overall quality of life.

About COPAXONE(R)

COPAXONE(R) is indicated for the reduction of the frequency of relapses in RRMS. The most common side effects of COPAXONE(R) are redness, pain, swelling, itching, a lump or an indentation at the site of injection, weakness, infection, pain, nausea, joint pain, anxiety, and muscle stiffness.

COPAXONE(R) is now approved in 47 countries worldwide, including the United States, Canada, Mexico, Australia, Israel, and all European countries. In North America, COPAXONE(R) is marketed by Teva Neuroscience, Inc., which is a subsidiary of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA). In Europe, COPAXONE(R) is marketed by Teva Pharmaceutical Industries Ltd. and sanofi-aventis. COPAXONE(R) is a registered trademark of Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 phar
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:11/26/2014)... RADNOR, Pa. , Nov. 26, 2014 ... dedicated to the development of innovative transdermal synthetic cannabinoid ... the Piper Jaffray 26th Annual Healthcare Conference 2014. The ... the New York Palace in New York ... , will present at 4:50 pm on Tuesday, December ...
(Date:11/26/2014)... -- According to the new research ... Battery, Pneumatic), by Product (Drill, Saw, Stapler, Reamer, ... (Orthopedic, ENT, Oral, Thoracic, Neurology) - Global Forecasts ... Instruments Market is estimated to be worth around ... expected to grow at a moderate CAGR during ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2
... 4, 2011 Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... North America beyond physician offices and outpatient clinics with the ... and reference laboratories. The new line is expected to be ... regulatory approval and other requirements. Roche Diagnostics ...
... CLEMENTE, Calif., Oct. 4, 2011 ReShape Medical®, Inc. ... and chief executive officer.  Interim CEO, Ken Charhut, will ... chairman of the board for ReShape Medical.   ... and CEO of Luminous Medical, Inc., an innovative glucose ...
Cached Medicine Technology:Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014 2ReShape Medical Names Richard Thompson President and Chief Executive Officer 2
(Date:11/27/2014)... Ericdress.com today announced a site-wide ... to 85% off, on all its clothing, shoes and other ... 1 – 7, 2014 only. , At the special offer, ... above $109 can enjoy an extra $10 discount. Moreover, orders ... business specially recommended its new collection of 2015 evening dresses ...
(Date:11/27/2014)... As everyone knows, Cyber Monday is a crazy shopping ... Tidebuy is now providing many big promotions on its ... 15% of the current prices. The discount are up to ... free shipping (for orders above $88) from Dec. 1 – ... and more people are willing to shop on the internet. ...
(Date:11/27/2014)... 28, 2014 Recently, DressVe , the ... Cyber Monday Sales, which are valid during Nov. 29 – ... available on these new dresses, up to 90% off. In ... Click to view more at http://www.dressve.com/ , Dresses ... a great way to showcase somebody’s personality and figure. The ...
(Date:11/27/2014)... 2014 The report “Blepharitis – ... the therapeutic development for Blepharitis, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Blepharitis and special features on late-stage and ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 TORQ Cycle is ... professional instructors who go out of the way to help ... people to get fit and do their workouts sincerely using ... they understand the fact that it is important for people ... past year, they have made sure that people take to ...
Breaking Medicine News(10 mins):Health News:Ericdress.com Special Monday Sales Are Ready For Everyone 2Health News:Tidebuy.com Launching Overcoats Sales for the Special Monday in 2014 2Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 2Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 3Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 4Health News:The new wave in Fitness : Stay Active with Innovative Indoor Cycling Programs 2
... technology reduces radiation exposure, eliminates workflow complexity, and ... MEDRAD,s Intego(TM) PET Infusion System has been named ... innovative products of the year. The magazine ... readership considers to be the most far-reaching, game ...
... Members Say Patient Care at Risk With Threats ... from three major unions representing more than 3,000 ... Care (ARH) facilities in eastern Kentucky and southern ... of directors to meet with them to discuss ...
... Foundation Health Plan,Inc., Kaiser Foundation Hospitals and their subsidiaries ... quarter ended December 31,2008, compared to $9.6 billion in ... million in the fourth quarter of 2008, compared to ... year. The difference between the two,quarters was primarily ...
... general health, functioning improve , , FRIDAY, Feb. 13 ... lose weight, exercise can improve postmenopausal women,s quality of ... sedentary postmenopausal women (average age 57.4) randomly assigned to ... groups: an exercise expenditure of 4 kilocalories per kilogram ...
... As the FDA and pharmaceutical manufacturers contemplate ... plans for extended release opioids, thousands of clinicians ... discovered a resource that supports the safe and ... in Pain ( www.emergingsolutionsinpain.com ) is a ...
... more to promote awareness, study says , , FRIDAY, Feb. 13 ... name or role -- the doctors assigned to their care, ... "The majority of hospitalized patients we looked at were not ... study author Dr. Vineet Arora, associate program director at the ...
Cached Medicine News:Health News:MEDRAD Molecular Imaging Earns Top Rank in Innovation 2Health News:MEDRAD Molecular Imaging Earns Top Rank in Innovation 3Health News:Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals' Bottom Line 2Health News:Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals' Bottom Line 3Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 2Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 3Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 4Health News:Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results 5Health News:Exercise Boosts Quality of Life in Postmenopausal Women 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 3Health News:Many Hospital Patients Can't ID Their Doctors 2Health News:Many Hospital Patients Can't ID Their Doctors 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: